ClinicalTrials.Veeva

Menu

LXR and Oocyte Meiosis Resumption

U

University Hospital, Clermont-Ferrand

Status

Unknown

Conditions

Female Infertility

Treatments

Other: IVF Procedure

Study type

Interventional

Funder types

Other

Identifiers

NCT03045315
CHU-303

Details and patient eligibility

About

Previous studies in animal model showed clearly that lipid homeostasis influence oocyte meiosis resumption. However Liver X Receptors pathway has never been investigated in human ovocyte

Full description

In mice deficient of Liver X Receptor (LXR) genes, the oocytes are unable to resume meiosis. Oxysterols are molecules derived from the cholesterol synthesis pathway. They are ligands of the liver X receptors (LXRs). In human, the LXR signalling pathway has never been investigated in this process. The Investigator propose to analyse in granulosa cells surrounding ovocyte the expression of LXR, their target genes and the enzymes involved in oxysterols synthesis. These granulosa cells are normally retrieved and destroyed 18 hours after sperm insemination of oocytes in a In Vitro Fertilization program. The oocyte meiosis resumption will be considered as positive (Granulosa cell positive, GC+) if a zygote is observed 18 hours after sperm insemination and negative (Granulosa cell negative, GC-) if none zygote appears. Moreover the investigator will analyse the quality of embryo development during 5 days after zygote is formed (normal process of In Vitro Fertilization) . The both populations of granulosa cells (GC+ and GC-) will be compared. The measurements of Liver X Receptor genes and the enzymes involved in oxysterols pathways xill be performed by Reverse Transcription-Polymerase Chain Reaction. The accumulation of lipid in granulosa cells will be measures by oil red staining. By this sudy the investigator will probably find new biological markers of resumption meiosis for women enrolled in In Vitro Fertilization programm. Moreover, data will help to better understand the physiopathology of oocyte meiosis failures.

Enrollment

250 estimated patients

Sex

Female

Ages

18 to 36 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • woman aged less 37 years
  • included in a IVF program
  • tubal infertility
  • ovarian stimulation with recombinant FSH
  • induced ovulation by recombinant chorionic gonaotrophin

Exclusion criteria

  • dysovulation
  • male infertility
  • Ovarian insuficiency

Trial design

250 participants in 1 patient group

women included in a IVF program
Experimental group
Treatment:
Other: IVF Procedure

Trial contacts and locations

1

Loading...

Central trial contact

Patrick LACARIN

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems